
The global market for Cognitive Diagnostics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Cognitive Diagnostics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cognitive Diagnostics.
The Cognitive Diagnostics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cognitive Diagnostics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cognitive Diagnostics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Cognetivity Neurosciences
Cognivue
Cogstate
Cambridge Cognition
Diadem
CN Diagnostics
Segment by Type
Alzheimer's Disease
Dementia
Other Neurological Disorders
Segment by Application
Hospitals
Neurology Clinics
Rehabilitation Centers
Academic and Research Institutes
Home Care
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Cognitive Diagnostics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Cognitive Diagnostics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Alzheimer's Disease
1.2.3 Dementia
1.2.4 Other Neurological Disorders
1.3 Market by Application
1.3.1 Global Cognitive Diagnostics Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospitals
1.3.3 Neurology Clinics
1.3.4 Rehabilitation Centers
1.3.5 Academic and Research Institutes
1.3.6 Home Care
1.3.7 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Cognitive Diagnostics Market Perspective (2020-2031)
2.2 Global Cognitive Diagnostics Growth Trends by Region
2.2.1 Global Cognitive Diagnostics Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Cognitive Diagnostics Historic Market Size by Region (2020-2025)
2.2.3 Cognitive Diagnostics Forecasted Market Size by Region (2026-2031)
2.3 Cognitive Diagnostics Market Dynamics
2.3.1 Cognitive Diagnostics Industry Trends
2.3.2 Cognitive Diagnostics Market Drivers
2.3.3 Cognitive Diagnostics Market Challenges
2.3.4 Cognitive Diagnostics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Cognitive Diagnostics Players by Revenue
3.1.1 Global Top Cognitive Diagnostics Players by Revenue (2020-2025)
3.1.2 Global Cognitive Diagnostics Revenue Market Share by Players (2020-2025)
3.2 Global Cognitive Diagnostics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Cognitive Diagnostics Revenue
3.4 Global Cognitive Diagnostics Market Concentration Ratio
3.4.1 Global Cognitive Diagnostics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Cognitive Diagnostics Revenue in 2024
3.5 Global Key Players of Cognitive Diagnostics Head office and Area Served
3.6 Global Key Players of Cognitive Diagnostics, Product and Application
3.7 Global Key Players of Cognitive Diagnostics, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Cognitive Diagnostics Breakdown Data by Type
4.1 Global Cognitive Diagnostics Historic Market Size by Type (2020-2025)
4.2 Global Cognitive Diagnostics Forecasted Market Size by Type (2026-2031)
5 Cognitive Diagnostics Breakdown Data by Application
5.1 Global Cognitive Diagnostics Historic Market Size by Application (2020-2025)
5.2 Global Cognitive Diagnostics Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Cognitive Diagnostics Market Size (2020-2031)
6.2 North America Cognitive Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Cognitive Diagnostics Market Size by Country (2020-2025)
6.4 North America Cognitive Diagnostics Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Cognitive Diagnostics Market Size (2020-2031)
7.2 Europe Cognitive Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Cognitive Diagnostics Market Size by Country (2020-2025)
7.4 Europe Cognitive Diagnostics Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Cognitive Diagnostics Market Size (2020-2031)
8.2 Asia-Pacific Cognitive Diagnostics Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Cognitive Diagnostics Market Size by Region (2020-2025)
8.4 Asia-Pacific Cognitive Diagnostics Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Cognitive Diagnostics Market Size (2020-2031)
9.2 Latin America Cognitive Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Cognitive Diagnostics Market Size by Country (2020-2025)
9.4 Latin America Cognitive Diagnostics Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Cognitive Diagnostics Market Size (2020-2031)
10.2 Middle East & Africa Cognitive Diagnostics Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Cognitive Diagnostics Market Size by Country (2020-2025)
10.4 Middle East & Africa Cognitive Diagnostics Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Cognetivity Neurosciences
11.1.1 Cognetivity Neurosciences Company Details
11.1.2 Cognetivity Neurosciences Business Overview
11.1.3 Cognetivity Neurosciences Cognitive Diagnostics Introduction
11.1.4 Cognetivity Neurosciences Revenue in Cognitive Diagnostics Business (2020-2025)
11.1.5 Cognetivity Neurosciences Recent Development
11.2 Cognivue
11.2.1 Cognivue Company Details
11.2.2 Cognivue Business Overview
11.2.3 Cognivue Cognitive Diagnostics Introduction
11.2.4 Cognivue Revenue in Cognitive Diagnostics Business (2020-2025)
11.2.5 Cognivue Recent Development
11.3 Cogstate
11.3.1 Cogstate Company Details
11.3.2 Cogstate Business Overview
11.3.3 Cogstate Cognitive Diagnostics Introduction
11.3.4 Cogstate Revenue in Cognitive Diagnostics Business (2020-2025)
11.3.5 Cogstate Recent Development
11.4 Cambridge Cognition
11.4.1 Cambridge Cognition Company Details
11.4.2 Cambridge Cognition Business Overview
11.4.3 Cambridge Cognition Cognitive Diagnostics Introduction
11.4.4 Cambridge Cognition Revenue in Cognitive Diagnostics Business (2020-2025)
11.4.5 Cambridge Cognition Recent Development
11.5 Diadem
11.5.1 Diadem Company Details
11.5.2 Diadem Business Overview
11.5.3 Diadem Cognitive Diagnostics Introduction
11.5.4 Diadem Revenue in Cognitive Diagnostics Business (2020-2025)
11.5.5 Diadem Recent Development
11.6 CN Diagnostics
11.6.1 CN Diagnostics Company Details
11.6.2 CN Diagnostics Business Overview
11.6.3 CN Diagnostics Cognitive Diagnostics Introduction
11.6.4 CN Diagnostics Revenue in Cognitive Diagnostics Business (2020-2025)
11.6.5 CN Diagnostics Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Cognetivity Neurosciences
Cognivue
Cogstate
Cambridge Cognition
Diadem
CN Diagnostics
Ìý
Ìý
*If Applicable.
